INDIA MARKET LENS

Laurus Labs Limited (LAURUSLABS): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Laurus Labs Limited, explained in plain English.

  • Laurus Labs Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
  • LAURUSLABS closed at ₹2,306.00 on 19 November 2026.
  • Over the past year the shares are up 133.5%, trading between ₹917.95 and ₹2,488.00.
  • Reported fundamentals show return on equity of 23.97%, a net margin of 17.13%, debt to equity of 42.47.
  • Our Pulse grade checklist scores it A (88/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
  • Annualised volatility over the past year is 31.85% with a maximum drawdown of -16.27% and a beta of 0.66 against NIFTY 50.
  • Recent coverage: HDFC Bank Share Price Live Updates: HNIs now own a record Rs 10 lakh crore worth of Indian stocks. Laurus Labs, Cupid among top 10 favourites
  • Recent coverage: Prime Focus among 4 stocks that closed above VWAP
  • Recent coverage: Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Anthem Biosciences, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma

Last traded values from 19 Nov 2026. Market opens at 9:15 IST.

Laurus Labs Limited (LAURUSLABS)

₹2,322.5

▼ 15.5 (-0.66%)

Price & volume

LAURUSLABS price chart, 1Y range. 252 points from 2025-11-20 to 2026-11-18. Opens at 987.1, closes at 2,322.5, ranging between 944.9 and 2,454.1,0001,5002,0002,500Nov-25Jan-26Mar-26Apr-26Jun-26Aug-26Sep-26Nov-26volume

Hover for exact price & volume · green/red volume bars show up vs down days

Strong momentum · 4/5
✓ Above 50-day avg✓ Above 200-day avgRSI 55.8 · healthyMACD negativeBollinger %B 57ADX 23.3 · weak trend

1M

+12.74%

3M

+28.03%

6M

+74.98%

1Y

+130.66%

Where it sits in its 52-week range

91%
₹944.9₹2,454

Below 52-week high

5.4%

145.8% above the low

Momentum read

Strong

4/5 checks passed

52-wk high

₹2,454

52-wk low

₹944.9

Market cap

₹1,25,488 Cr

P/E (trailing)

93.7

Dividend yield

—

ROE

23.97%

Profit margin

17.13%

Revenue growth

33.4%

Price / Book

20.71

Debt / Equity

42.47

EPS (TTM)

24.78

Book value

₹112.16

Beta

0.67

Pulse grade: A, 88 out of 100

Momentum

A
  • ✓Trading above 50-day average
  • ✓Trading above 200-day average
  • ✓RSI in healthy 45-70 zone
  • ✓Positive 3-month return

Growth

A
  • ✓Revenue growth above Pharma & Healthcare median (20.8%)
  • ✓Revenue growing above 5%
  • ✓Quarterly profits trending up

Profitability

A
  • ✓Return on equity above Pharma & Healthcare median (14.56%)
  • ✓Return on equity above 12%
  • ✓Profit margin above Pharma & Healthcare median (13.82%)

Safety

D
  • ✕Debt below Pharma & Healthcare median (18.57)
  • ✓Debt not extreme for the sector
  • ✓Less volatile than the market (beta < 1.2)
  • ✕Pays a dividend

Quarterly revenue vs net profit

Revenue Net profit₹ crore, by quarter

Sep 2026: revenue ₹2,206 crore · net profit ₹441 crore · margin 20.0%

2,2060Jun 2025n/aSep 2025Dec 2025Mar 2026Jun 2026Sep 2026

Business quality

Intrinsic value

Building the model…

Analyst coverage

Who owns this company

Events, dividends & splits

Market position

Pharma & Healthcare sector

PeerPrice ₹Day changeFrom 52-wk high
SUNPHARMA1,871.5+0.08%-6.48%
DRREDDY1,398.2+0.73%0.00%
CIPLA1,417+2.09%-7.46%
DIVISLAB11,049-0.91%-4.47%
APOLLOHOSP8,821+1.25%-2.73%
LUPIN1,971.9+1.12%-21.59%

LAURUSLABS headlines

No LAURUSLABS stories right now.

LAURUSLABS filings & announcements

Reading the exchange…

LAURUSLABS, historical timeline

The timeline will be ready shortly

The rest of the page is unaffected.

Risk & return, last 12 months

Volatility (ann.)

31.86%

Sharpe ratio

2.66

Sortino ratio

4.41

Max drawdown

-16.27%

Daily VaR (95%)

-2.72%

CAGR (1Y)

136.09%

Return skew

0.07

Sharpe/Sortino use a 7% risk-free rate. VaR-95 = the daily loss exceeded only 5% of days last year.

Risk profile over time

Quant tearsheet

Monthly returns, how deep the falls ran, and how tightly it tracks NIFTY.